CRVS $2.99 (-6.85%) Quote details
Add to Watchlist Run Backtest
Establish your trading edge with a set of smart tools for serious trades. Upgrade Account
stock

Corvus Pharmaceuticals Inc

NASDAQ | CRVS

2.99

USD

-0.22 (-6.85%)

AT CLOSE (AS OF Apr 3, 2025)

$219M

MARKET CAP

-

P/E Ratio

-1.02

EPS

$10

52 Week High

$1.3

52 Week Low

LIFE SCIENCES

Sector

CRVS Chart

1D
Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests
Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals
Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

CRVS Technicals

Tags:

CRVS Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field Value (USD)
Gross Profit -$12M
Total Revenue -
Cost Of Revenue $7.1M
Costof Goods And Services Sold $151K
Operating Income -$23M
Selling General And Administrative $6.9M
Research And Development $17M
Operating Expenses $23M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $1.6M
Interest Expense $1.6M
Non Interest Income -$5.3M
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $200K
Income Before Tax -$27M
Income Tax Expense $0
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -$27M
Ebit -$23M
Ebitda -$23M
Net Income -$27M

Revenue & Profitability

Earnings Performance

CRVS Financials

yearly Balance Sheet (As of Dec 31, 2023)

Field Value (USD)
Total Assets $46M
Total Current Assets $28M
Cash And Cash Equivalents At Carrying Value $13M
Cash And Short Term Investments $27M
Inventory -
Current Net Receivables $26K
Total Non Current Assets $18M
Property Plant Equipment $236K
Accumulated Depreciation Amortization Ppe $4.7M
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments $31M
Long Term Investments $16M
Short Term Investments $14M
Other Current Assets $220K
Other Non Current Assets $89K
Total Liabilities $6.9M
Total Current Liabilities $6.9M
Current Accounts Payable $1.5M
Deferred Revenue -
Current Debt -
Short Term Debt $1.4M
Total Non Current Liabilities -
Capital Lease Obligations $1.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.4M
Other Current Liabilities $4M
Other Non Current Liabilities -
Total Shareholder Equity $39M
Treasury Stock -
Retained Earnings -$335M
Common Stock $5K
Common Stock Shares Outstanding $49M

yearly Cash Flow (As of Dec 31, 2023)

Field Value (USD)
Operating Cashflow -$24M
Payments For Operating Activities $1.8M
Proceeds From Operating Activities -
Change In Operating Liabilities -$451K
Change In Operating Assets -$594K
Depreciation Depletion And Amortization $151K
Capital Expenditures $34K
Change In Receivables -$562K
Change In Inventory -
Profit Loss -$27M
Cashflow From Investment $16M
Cashflow From Financing $7.9M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $12K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$27M

yearly Income Statement (As of Dec 31, 2023)

Field Value (USD)
Gross Profit -$12M
Total Revenue -
Cost Of Revenue $7.1M
Costof Goods And Services Sold $151K
Operating Income -$23M
Selling General And Administrative $6.9M
Research And Development $17M
Operating Expenses $23M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $1.6M
Interest Expense $1.6M
Non Interest Income -$5.3M
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $200K
Income Before Tax -$27M
Income Tax Expense $0
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -$27M
Ebit -$23M
Ebitda -$23M
Net Income -$27M

CRVS Profile

Corvus Pharmaceuticals Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. The company is headquartered in Burlingame, California.

DMN
9.42%
$0.0151
NVDA
-7.81%
$101.8
INTC
2.05%
$22.43
F
-5.96%
$9.545
LCID
-3.33%
$2.32
STSS
8.79%
$0.0297
PTIX
84.14%
$0.418
LGMK
-15.96%
$0.0158
TSLA
-5.47%
$267.28
BAC
-11.06%
$37.22
NIVF
-4.75%
$0.561
MGOL
-20.43%
$0.37
DGLY
9.09%
$0.036
AAPL
-9.25%
$203.19
AMZN
-8.98%
$178.41
PLTR
-4.40%
$83.6
ALTM
0.00%
$5.84
OSRH
68.03%
$2.47
LILM
-36.97%
$0.052
AAL
-10.25%
$9.505
APVO
44.20%
$1.99
SOFI
-13.57%
$10.64
BON
-12.81%
$0.0633
NKE
-14.59%
$55.485
BTE
-10.54%
$1.995
GNPX
46.31%
$0.4316
HOOD
-10.36%
$38.26
DNN
-4.23%
$1.245
MULN
-22.82%
$0.0795
BBD
3.30%
$2.29
LYT
-16.78%
$0.0982
MRM
87.76%
$0.6947
PFE
-1.66%
$24.29
VALE
-3.57%
$9.73
WBD
-13.26%
$9.16
BTG
-0.17%
$2.915
PMAX
-2.68%
$0.435
SNAP
-9.74%
$8.015
JYD
24.25%
$0.4293
AMD
-8.90%
$93.8
PLUG
-8.33%
$1.21
T
1.63%
$28.6
ABEV
2.54%
$2.42
CCL
-13.69%
$17.28
GOOGL
-4.02%
$150.72
MU
-16.09%
$74.34
SMCI
-7.89%
$32.32
AVGO
-10.51%
$154.01
RIG
-13.92%
$2.72
LYG
-4.56%
$3.665
CSCO
-7.30%
$57.31
C
-12.14%
$63.05
RIVN
-7.69%
$11.53
JBLU
-17.36%
$4.165
AGNC
-1.48%
$9.34
KSS
-22.79%
$6.64
NKLA
-28.74%
$0.183
NIO
-1.32%
$3.75
ITUB
2.71%
$5.68
UAA
-18.79%
$5.36
HPE
-15.23%
$13.665
ATPC
-0.78%
$1.28
TIVC
49.85%
$4.87
VFC
-28.80%
$11.67
AMCR
-2.50%
$9.555
META
-8.96%
$531.62
CLF
-16.90%
$7.255
WMT
-2.83%
$87.22
IQ
-4.57%
$2.09
STLA
-9.36%
$10.215
FCX
-12.28%
$33.51
VRN
-6.06%
$6.275
HBAN
-11.51%
$13.46
QBTS
-2.72%
$7.14
MSFT
-2.36%
$373.11
ET
-6.31%
$17.735
BABA
-0.30%
$129.4
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
NCLH
-16.36%
$16.31
RGTI
-4.00%
$8.15
MCHP
-16.80%
$40.71
ERIC
-3.98%
$7.48
TSM
-7.64%
$157.38
GOOG
-3.92%
$152.63
GRAB
-7.59%
$4.26
APLD
2.46%
$6.24
GAP
-20.29%
$17.84
CRWV
-12.32%
$53.8
NOK
-6.92%
$4.98
CX
-2.28%
$5.56
MARA
-9.58%
$11.23
WFC
-9.12%
$65.67
BCS
-9.02%
$14.32
PCG
-0.98%
$17.26
FSM
-2.40%
$6.09
MRVL
-12.00%
$55.64
KO
2.59%
$73.18
OXY
-11.01%
$43.9
VZ
2.03%
$45.6469
DMN
9.42%
$0.0151
NVDA
-7.81%
$101.8
INTC
2.05%
$22.43
F
-5.96%
$9.545
LCID
-3.33%
$2.32
STSS
8.79%
$0.0297
PTIX
84.14%
$0.418
LGMK
-15.96%
$0.0158
TSLA
-5.47%
$267.28
BAC
-11.06%
$37.22
NIVF
-4.75%
$0.561
MGOL
-20.43%
$0.37
DGLY
9.09%
$0.036
AAPL
-9.25%
$203.19
AMZN
-8.98%
$178.41
PLTR
-4.40%
$83.6
ALTM
0.00%
$5.84
OSRH
68.03%
$2.47
LILM
-36.97%
$0.052
AAL
-10.25%
$9.505
APVO
44.20%
$1.99
SOFI
-13.57%
$10.64
BON
-12.81%
$0.0633
NKE
-14.59%
$55.485
BTE
-10.54%
$1.995
GNPX
46.31%
$0.4316
HOOD
-10.36%
$38.26
DNN
-4.23%
$1.245
MULN
-22.82%
$0.0795
BBD
3.30%
$2.29
LYT
-16.78%
$0.0982
MRM
87.76%
$0.6947
PFE
-1.66%
$24.29
VALE
-3.57%
$9.73
WBD
-13.26%
$9.16
BTG
-0.17%
$2.915
PMAX
-2.68%
$0.435
SNAP
-9.74%
$8.015
JYD
24.25%
$0.4293
AMD
-8.90%
$93.8
PLUG
-8.33%
$1.21
T
1.63%
$28.6
ABEV
2.54%
$2.42
CCL
-13.69%
$17.28
GOOGL
-4.02%
$150.72
MU
-16.09%
$74.34
SMCI
-7.89%
$32.32
AVGO
-10.51%
$154.01
RIG
-13.92%
$2.72
LYG
-4.56%
$3.665
CSCO
-7.30%
$57.31
C
-12.14%
$63.05
RIVN
-7.69%
$11.53
JBLU
-17.36%
$4.165
AGNC
-1.48%
$9.34
KSS
-22.79%
$6.64
NKLA
-28.74%
$0.183
NIO
-1.32%
$3.75
ITUB
2.71%
$5.68
UAA
-18.79%
$5.36
HPE
-15.23%
$13.665
ATPC
-0.78%
$1.28
TIVC
49.85%
$4.87
VFC
-28.80%
$11.67
AMCR
-2.50%
$9.555
META
-8.96%
$531.62
CLF
-16.90%
$7.255
WMT
-2.83%
$87.22
IQ
-4.57%
$2.09
STLA
-9.36%
$10.215
FCX
-12.28%
$33.51
VRN
-6.06%
$6.275
HBAN
-11.51%
$13.46
QBTS
-2.72%
$7.14
MSFT
-2.36%
$373.11
ET
-6.31%
$17.735
BABA
-0.30%
$129.4
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
NCLH
-16.36%
$16.31
RGTI
-4.00%
$8.15
MCHP
-16.80%
$40.71
ERIC
-3.98%
$7.48
TSM
-7.64%
$157.38
GOOG
-3.92%
$152.63
GRAB
-7.59%
$4.26
APLD
2.46%
$6.24
GAP
-20.29%
$17.84
CRWV
-12.32%
$53.8
NOK
-6.92%
$4.98
CX
-2.28%
$5.56
MARA
-9.58%
$11.23
WFC
-9.12%
$65.67
BCS
-9.02%
$14.32
PCG
-0.98%
$17.26
FSM
-2.40%
$6.09
MRVL
-12.00%
$55.64
KO
2.59%
$73.18
OXY
-11.01%
$43.9
VZ
2.03%
$45.6469
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.